Tussilagone Alleviates Sepsis-Induced Lung Injury and Modulates PTGS2-Associated Macrophage Inflammation: Integrating Transcriptomics, Machine Learning, and Experimental Validation

Background: Sepsis-induced lung injury (SILI) is a severe complication of sepsis, and the mechanisms underlying the protective effects of tussilagone (TS) remain incompletely understood. Objectives: This study aimed to prioritize TS-associated targets relevant to SILI and investigate their functional involvement in macrophage inflammation. Methods: Transcriptomics, weighted gene co-expression network analysis, network pharmacology, and nested-cross-validation machine learning were integrated with lung single-cell analysis and molecular simulations. Protective effects were evaluated in cecal ligation and puncture (CLP) mice and lipopolysaccharide-stimulated macrophages. Target engagement and functional involvement were assessed using biochemical, genetic, and pharmacological approaches. Results: PTGS2 and IL1B were consistently selected during machine learning analysis, with PTGS2 showing relatively prominent model importance and concordant expression changes across three peripheral-blood cohorts. Lung single-cell analysis identified macrophages/monocytes as a prominent PTGS2-expressing population. Molecular simulations suggested a potential TS–PTGS2 interaction. Prophylactic TS administration attenuated CLP-induced lung injury and suppressed inflammatory responses in stimulated macrophages. Drug affinity responsive target stability and cellular thermal shift assays provided evidence consistent with PTGS2 engagement. PTGS2 knockdown and rescue, together with pharmacological inhibition, supported its functional involvement in the anti-inflammatory response to TS. TS also inhibited recombinant human COX-2 activity (IC50 = 9.58 μM). Conclusions: These findings demonstrate protective effects of prophylactic TS in experimental SILI and support PTGS2/COX-2 involvement in its anti-inflammatory actions in macrophages.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-16
DOI
https://doi.org/10.3390/ph19111819
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tussilagone Alleviates Sepsis-Induced Lung Injury and Modulates PTGS2-Associated Macrophage Inflammation: Integrating Transcriptomics, Machine Learning, and Experimental Validation

Linxi Lv, Wei Gu, Wenzhan Xie
7 links
Pharmaceuticals
Sepsis Diagnosis and Treatment
article

Tussilagone Alleviates Sepsis-Induced Lung Injury and Modulates PTGS2-Associated Macrophage Inflammation: Integrating Transcriptomics, Machine Learning, and Experimental Validation

Linxi Lv, Wei Gu, Wenzhan Xie
article en

Abstract

Background: Sepsis-induced lung injury (SILI) is a severe complication of sepsis, and the mechanisms underlying the protective effects of tussilagone (TS) remain incompletely understood. Objectives: This study aimed to prioritize TS-associated targets relevant to SILI and investigate their functional involvement in macrophage inflammation. Methods: Transcriptomics, weighted gene co-expression network analysis, network pharmacology, and nested-cross-validation machine learning were integrated with lung single-cell analysis and molecular simulations. Protective effects were evaluated in cecal ligation and puncture (CLP) mice and lipopolysaccharide-stimulated macrophages. Target engagement and functional involvement were assessed using biochemical, genetic, and pharmacological approaches. Results: PTGS2 and IL1B were consistently selected during machine learning analysis, with PTGS2 showing relatively prominent model importance and concordant expression changes across three peripheral-blood cohorts. Lung single-cell analysis identified macrophages/monocytes as a prominent PTGS2-expressing population. Molecular simulations suggested a potential TS–PTGS2 interaction. Prophylactic TS administration attenuated CLP-induced lung injury and suppressed inflammatory responses in stimulated macrophages. Drug affinity responsive target stability and cellular thermal shift assays provided evidence consistent with PTGS2 engagement. PTGS2 knockdown and rescue, together with pharmacological inhibition, supported its functional involvement in the anti-inflammatory response to TS. TS also inhibited recombinant human COX-2 activity (IC50 = 9.58 μM). Conclusions: These findings demonstrate protective effects of prophylactic TS in experimental SILI and support PTGS2/COX-2 involvement in its anti-inflammatory actions in macrophages.

PharmaceuticalsVol. 19(11)
Chongqing University (CN)
National Natural Science Foundation of China
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon